{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:30:29Z","timestamp":1768422629917,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T00:00:00Z","timestamp":1478476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T00:00:00Z","timestamp":1478476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DP1DA031401"],"award-info":[{"award-number":["DP1DA031401"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40360-016-0093-6","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T16:12:17Z","timestamp":1476375137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats"],"prefix":"10.1186","volume":"17","author":[{"given":"Shamia L.","family":"Faison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles W.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"93_CR1","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMra0809890","volume":"362","author":"N Benowitz","year":"2010","unstructured":"Benowitz N. Nicotine addiction. N Engl J Med. 2010;362:2295\u2013303.","journal-title":"N Engl J Med"},{"key":"93_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","volume":"49","author":"N Benowitz","year":"2009","unstructured":"Benowitz N. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57\u201371.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"93_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.01.015","volume":"121","author":"N Benowitz","year":"2008","unstructured":"Benowitz N. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med. 2008;121:S3\u201310.","journal-title":"Am J Med"},{"key":"93_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.coph.2012.02.005","volume":"12","author":"P Caponnetto","year":"2012","unstructured":"Caponnetto P, Russo C, Polosa R. Smoking cessation: present status and future perspectives. Curr Opin Pharmacol. 2012;12:229\u201337.","journal-title":"Curr Opin Pharmacol"},{"key":"93_CR5","first-page":"1513","volume":"2014","author":"Centers for Disease Control and Prevention","year":"2014","unstructured":"Centers for Disease Control and Prevention. Quitting smoking among Adults\u2014United states, 2001\u20132010. Morb Mortal Wkly Rep. 2014;2014:1513\u20139.","journal-title":"Morb Mortal Wkly Rep"},{"key":"93_CR6","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1021\/jm050069n","volume":"48","author":"J Coe","year":"2005","unstructured":"Coe J, Brooks P, Vetelino M, Wirtz M, Arnold E, Huang J, Sands S, Davis T, Lebel L, Fox C, Shrikhande A, Heym J, Schaeffer E, Rollema H, Lu Y, Mansbach R, Chambers L, Rovetti C, Schulz D, Tingley FD, O\u2019Neill B. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48:3474\u20137.","journal-title":"J Med Chem"},{"key":"93_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0091-3057(01)00652-9","volume":"70","author":"JA Dani","year":"2001","unstructured":"Dani JA, De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav. 2001;70:439\u201346.","journal-title":"Pharmacol Biochem Behav"},{"key":"93_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.drugalcdep.2010.11.023","volume":"116","author":"Y Figueroa-Guzman","year":"2010","unstructured":"Figueroa-Guzman Y, Mueller C, Vranjkovic O, Wisniewski S, Yang Z, Li SJ, Bohr C, Graf EN, Baker DA, Mantsch JR. Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats. Drug Alcohol Depend. 2010;116:72\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"93_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1368-5031.2006.00955.x","volume":"60","author":"J Foulds","year":"2006","unstructured":"Foulds J. The neurobiological basis for partial agonist treatment of nicotine dependence: Varenicline. Int J Clin Pract. 2006;60:571\u20136.","journal-title":"Int J Clin Pract"},{"key":"93_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1300\/J069v17n01_02","volume":"17","author":"MS Gold","year":"1998","unstructured":"Gold MS, Herkov MJ. Tobacco smoking and nicotine dependence: Biological basis for pharmacotherapy from nicotine to treatments that prevent relapse. J Addict Dis. 1998;17:7\u201321.","journal-title":"J Addict Dis"},{"key":"93_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","volume":"43","author":"J Hughes","year":"1986","unstructured":"Hughes J. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43:289.","journal-title":"Arch Gen Psychiatry"},{"key":"93_CR12","first-page":"281","volume":"35","author":"R Jain","year":"2003","unstructured":"Jain R, Mukherjee K. Biological basis of nicotine addiction. Indian J Pharmacol. 2003;35:281\u20139.","journal-title":"Indian J Pharmacol"},{"key":"93_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4103\/0019-5545.74303","volume":"52","author":"RC Jiloha","year":"2010","unstructured":"Jiloha RC. Biological basis of tobacco addiction: Implications for smoking-cessation treatment. Indian J Psychiatry. 2010;52:301\u20137.","journal-title":"Indian J Psychiatry"},{"key":"93_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"G Koob","year":"2010","unstructured":"Koob G, Volkow N. Neurocircuitry of addiction. Neuropsychopharmacology. 2010;35:217\u201338.","journal-title":"Neuropsychopharmacology"},{"key":"93_CR15","doi-asserted-by":"crossref","unstructured":"Le Foll B, Chakraborty Chatterjee M, Lev Ran S, Barnes C, Pushparaj A, Gamaleddin I, Yan Y, Khaled M, Goldberg S. Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used. Int J Neuropsychopharmacol. 2012;9:1265\u201374.","DOI":"10.1017\/S1461145711001398"},{"key":"93_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4062\/biomolther.2014.032","volume":"22","author":"B Lee","year":"2014","unstructured":"Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm D. L-tetrahydropalmatine ameliorates development of anxiety and depression-related symptoms induced by single prolonged stress in rats. Biomol Ther. 2014;22:213\u201322.","journal-title":"Biomol Ther"},{"key":"93_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.mri.2011.09.006","volume":"30","author":"X Liu","year":"2012","unstructured":"Liu X, Yang Z, Li R, Xie J, Yin Q, Bloom A, Li S. Responses of dopaminergic, serotonergic and noradrenergic networks to acute levo-tetrahydropalmatine administration in na\u00efve rats detected at 9.4T. Magn Reson Imaging. 2012;30:261\u201370.","journal-title":"Magn Reson Imaging"},{"key":"93_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00213-007-0967-9","volume":"196","author":"X Liu","year":"2008","unstructured":"Liu X, Caggiula A, Palmatier M, Donny E, Sved A. Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose. Psychopharmacology (Berl). 2008;196:365\u201375.","journal-title":"Psychopharmacology (Berl)"},{"key":"93_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00213-007-0754-7","volume":"192","author":"JR Mantsch","year":"2007","unstructured":"Mantsch JR, Li SJ, Risinger R, Awad S, Katz E, Baker DA, Yang Z. Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats. Psychopharmacology (Berl). 2007;192:581\u201391.","journal-title":"Psychopharmacology (Berl)"},{"key":"93_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.pbb.2010.08.016","volume":"97","author":"JR Mantsch","year":"2010","unstructured":"Mantsch JR, Wisniewski S, Vranjkovic O, Peters C, Becker A, Valentine A, Li SJ, Baker DA, Yang Z. Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats. Pharmacol Biochem Behav. 2010;97:310\u20136.","journal-title":"Pharmacol Biochem Behav"},{"key":"93_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF00175196","volume":"89","author":"F Marcenac","year":"1986","unstructured":"Marcenac F, Jin GZ, Gonon F. Effect of l-tetrahydropalmatine on dopamine release and metabolism in the rat striatum. Psychopharmacology (Berl). 1986;89:89\u201393.","journal-title":"Psychopharmacology (Berl)"},{"key":"93_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.tips.2010.12.008","volume":"32","author":"R Polosa","year":"2011","unstructured":"Polosa R, Benowitz N. Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci. 2011;32:281\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"93_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1046\/j.1471-4159.2000.740684.x","volume":"74","author":"S Rahman","year":"2000","unstructured":"Rahman S, McBride WJ. Feedback control of mesolimbic somatodendritic dopamine release in rat brain. J Neurochem. 2000;74:684\u201392.","journal-title":"J Neurochem"},{"key":"93_CR24","first-page":"23","volume":"2","author":"D Robinson","year":"2011","unstructured":"Robinson D, Zitzman D, Williams S. Mesolimbic dopamine transients in motivated behaviors: focus on maternal behavior. Front Psych. 2011;2:23.","journal-title":"Front Psych"},{"key":"93_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1196\/annals.1441.019","volume":"1141","author":"J Rose","year":"2008","unstructured":"Rose J. Disrupting nicotine reinforcement: from cigarette to brain. Ann N Y Acad Sci. 2008;1141:233\u201356.","journal-title":"Ann N Y Acad Sci"},{"key":"93_CR26","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1523\/JNEUROSCI.22-08-03293.2002","volume":"22","author":"F Rouge Pont","year":"2002","unstructured":"Rouge Pont F, Usiello A, Benoit Marand M, Gonon F, Piazza P, Borrelli E. Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci. 2002;22:3293\u2013301.","journal-title":"J Neurosci"},{"key":"93_CR27","doi-asserted-by":"crossref","unstructured":"Solinas M, Panlilio LV, Antoniou K, Pappas LA, Goldberg SR. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J Pharmacol Exp Ther. 2003;306:93\u2013102.","DOI":"10.1124\/jpet.102.047928"},{"key":"93_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.physbeh.2013.05.034","volume":"118","author":"H Su","year":"2013","unstructured":"Su H, Zhu J, Chen Y, Zhao N, Han W, Dang Y, Xu M, Chen T. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior. Physiol Behav. 2013;118:195\u2013200.","journal-title":"Physiol Behav"},{"key":"93_CR29","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1124\/jpet.104.080465","volume":"313","author":"G Tanda","year":"2005","unstructured":"Tanda G, Ebbs A, Newman A, Katz J. Effects of 4\u2032-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine. J Pharmacol Exp Ther. 2005;313:613\u201320.","journal-title":"J Pharmacol Exp Ther"},{"key":"93_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4155\/fmc.11.166","volume":"4","author":"J Wang","year":"2012","unstructured":"Wang J, Mantsch J. l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction. Future Med Chem. 2012;4:177\u201386.","journal-title":"Future Med Chem"},{"key":"93_CR31","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.neuropharm.2007.08.004","volume":"53","author":"ZX Xi","year":"2007","unstructured":"Xi ZX, Yang Z, Li SJ, Li X, Dillon C, Peng XQ, Spiller K, Gardner EL. Levo-tetrahydropalmatine inhibits cocaine\u2019s rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropharmacology. 2007;53:771\u201382.","journal-title":"Neuropharmacology"},{"key":"93_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1527-3458.2007.00013.x","volume":"13","author":"Z Xi","year":"2007","unstructured":"Xi Z, Gardner E. Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction. CNS Drug Rev. 2007;13:240\u201359.","journal-title":"CNS Drug Rev"},{"key":"93_CR33","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1745-7254.2008.00817.x","volume":"29","author":"Z Yang","year":"2008","unstructured":"Yang Z, Shao YC, Li SJ, Qi JL, Zhang MJ, Hao W, Jin GZ. Medication of l\u2010tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: A pilot study. Acta Pharmacol Sin. 2008;29:781\u20138.","journal-title":"Acta Pharmacol Sin"},{"key":"93_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2012.03.014","volume":"102","author":"K Yue","year":"2012","unstructured":"Yue K, Yue. The dopamine receptor antagonist levo-tetrahydropalmatine attenuates heroin self-administration and heroin-induced reinstatement in rats. Pharmacol Biochem Behav. 2012;102:1\u20135.","journal-title":"Pharmacol Biochem Behav"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-016-0093-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-016-0093-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-016-0093-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T14:28:05Z","timestamp":1589552885000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-016-0093-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["93"],"URL":"https:\/\/doi.org\/10.1186\/s40360-016-0093-6","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,7]]},"assertion":[{"value":"14 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"49"}}